A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

NCT00000896 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate
DRUG: Lamivudine/Zidovudine
BIOLOGICAL: Hepatitis A Vaccine (Inactivated)
DRUG: Interleukin-12
DRUG: Nevirapine
DRUG: Stavudine
DRUG: Sargramostim

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)